Neural Therapeutics (FRA:M6B) Receivables Turnover : 0.00 (As of Oct. 2024)

View and export this data going back to 2025. Start your Free Trial

What is Neural Therapeutics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Neural Therapeutics's Revenue for the three months ended in Oct. 2024 was €0.00 Mil. Neural Therapeutics's average Accounts Receivable for the three months ended in Oct. 2024 was €0.00 Mil.

Neural Therapeutics Receivables Turnover Historical Data

The historical data trend for Neural Therapeutics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neural Therapeutics Receivables Turnover Chart

Neural Therapeutics Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Receivables Turnover

Neural Therapeutics Quarterly Data
	Jul20	Jul21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Receivables Turnover	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Neural Therapeutics's Receivables Turnover

For the Biotechnology subindustry, Neural Therapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neural Therapeutics's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neural Therapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Neural Therapeutics's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Neural Therapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Neural Therapeutics's Receivables Turnover for the fiscal year that ended in Jul. 2024 is calculated as

	Receivables Turnover (A: Jul. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jul. 2024 )	/ (	(Accounts Receivable (A: Jul. 2023 )	+	Accounts Receivable (A: Jul. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Neural Therapeutics's Receivables Turnover for the quarter that ended in Oct. 2024 is calculated as

	Receivables Turnover (Q: Oct. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Oct. 2024 )	/ (	(Accounts Receivable (Q: Jul. 2024 )	+	Accounts Receivable (Q: Oct. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Neural Therapeutics (FRA:M6B) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Neural Therapeutics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Neural Therapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Neural Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neural Therapeutics Inc (FRA:M6B) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

NURL:Canada

Address

130 Adelaide Street, Suite 3002, Toronto, ON, CAN, M5H 3P5

Website

https://www.neuraltherapeutics.ca

Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.

Neural Therapeutics Headlines

No Headlines